Foresite Capital Management V, LLC Diversified Active

CIK: 0001792206 · Show all filings

Period: Q3 2021 (← Previous) (Next →)

Filing Date: Nov 12, 2021

Total Value ($000): $321,757 (100.0% shares, 0.0% debt)

Holdings (17)

— Somalogic, Inc. 20.5%

Value ($000) $65,995 Shares 5,326,472 Est. Cost $12.39 Unrealized —

CGEM Cullinan Oncology, Inc. 19.2%

Value ($000) $61,648 Shares 2,731,410 Est. Cost $40.60 Unrealized -34.1%

IVVD Adagio Therapeutics, Inc. 16.8%

Value ($000) $54,094 Shares 1,280,640 Est. Cost $37.11 Unrealized 0.0%

ACRS Aclaris Therapeutics, Inc. 7.0%

Value ($000) $22,648 Shares 1,258,243 Est. Cost $19.56 Unrealized -18.0%

— Kinnate Biopharma Inc. 6.3%

Value ($000) $20,143 Shares 875,001 Est. Cost $39.78 Unrealized —

QSI Quantum-Si Incorporated 6.1%

Value ($000) $19,533 Shares 2,342,061 Est. Cost $10.48 Unrealized -6.0%

HLTHQ Cue Health Inc. 4.3%

Value ($000) $13,792 Shares 1,167,782 Est. Cost $11.81 Unrealized —

NRIX Nurix Therapeutics, Inc. 4.2%

Value ($000) $13,528 Shares 451,522 Est. Cost $33.14 Unrealized -6.9%

— Gemini Therapeutics, Inc. 3.1%

Value ($000) $9,838 Shares 2,435,125 Est. Cost $13.55 Unrealized —

HIMS Hims & Hers Health, Inc. 2.5%

Value ($000) $7,969 Shares 1,056,922 Est. Cost $16.76 Unrealized -49.5%

PHVS Pharvaris N.V. 2.0%

Value ($000) $6,456 Shares 364,142 Est. Cost $31.46 Unrealized -45.6%

— 23andMe Holding Co. 2.0%

Value ($000) $6,342 Shares 700,000 Est. Cost $11.69 Unrealized —

— FS Development Corp. II 1.9%

Value ($000) $5,995 Shares 602,500 Est. Cost $9.96 Unrealized —

— Population Health Investment Co., Inc. 1.7%

Value ($000) $5,603 Shares 960,000 Est. Cost $10.45 Unrealized —

— Research Alliance Corp. II 1.5%

Value ($000) $4,925 Shares 500,000 Est. Cost $10.25 Unrealized —

MLTX Helix Acquisition Corp. 0.8%

Value ($000) $2,488 Shares 250,000 Est. Cost $11.37 Unrealized —

— Lucira Health, Inc. 0.2%

Value ($000) $760 Shares 485,000 Est. Cost $12.10 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Somalogic, Inc.	5,326,472	$65,995	20.5%	$12.39	—	COM CL A	83444K105
CGEM	Cullinan Oncology, Inc.	2,731,410	$61,648	19.2%	$40.60	-34.1%	COM	230031106
IVVD	Adagio Therapeutics, Inc.	1,280,640	$54,094	16.8%	$37.11	0.0%	COM	00534A102
ACRS	Aclaris Therapeutics, Inc.	1,258,243	$22,648	7.0%	$19.56	-18.0%	COM	00461U105
—	Kinnate Biopharma Inc.	875,001	$20,143	6.3%	$39.78	—	COM	49705R105
QSI	Quantum-Si Incorporated	2,342,061	$19,533	6.1%	$10.48	-6.0%	COM CL A	74765K105
HLTHQ	Cue Health Inc.	1,167,782	$13,792	4.3%	$11.81	—	COM	229790100
NRIX	Nurix Therapeutics, Inc.	451,522	$13,528	4.2%	$33.14	-6.9%	COM	67080M103
—	Gemini Therapeutics, Inc.	2,435,125	$9,838	3.1%	$13.55	—	COM	36870G105
HIMS	Hims & Hers Health, Inc.	1,056,922	$7,969	2.5%	$16.76	-49.5%	COM CL A	433000106
PHVS	Pharvaris N.V.	364,142	$6,456	2.0%	$31.46	-45.6%	COM	N69605108
—	23andMe Holding Co.	700,000	$6,342	2.0%	$11.69	—	COM CL A	90138Q108
—	FS Development Corp. II	602,500	$5,995	1.9%	$9.96	—	COM CL A	30318F100
—	Population Health Investment Co., Inc.	960,000	$5,603	1.7%	$10.45	—	UNIT	G71716123
—	Research Alliance Corp. II	500,000	$4,925	1.5%	$10.25	—	COM CL A	760873109
MLTX	Helix Acquisition Corp.	250,000	$2,488	0.8%	$11.37	—	COM CL A	G4444C102
—	Lucira Health, Inc.	485,000	$760	0.2%	$12.10	—	COM	54948U105